NIELSEN PETER E has a total of 17 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are TOCAGEN INC, CHILDRENS HOSPITAL INC and JP NAT INST INFECTIOUS DISEASE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 4 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | Japan | 1 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Sugars | |
#7 | Enzymes | |
#8 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Nielsen Peter E | 12 |
#2 | Knudsen Helle | 5 |
#3 | Good Liam | 4 |
#4 | Buchardt Ole | 4 |
#5 | Egholm Michael | 3 |
#6 | Haaima Gerald | 2 |
#7 | Eldrup Anne B | 2 |
#8 | Berg Rolf H | 2 |
#9 | Norden Benget | 1 |
#10 | Berg Rolf | 1 |
Publication | Filing date | Title |
---|---|---|
US6350853B1 | Conjugated peptide nucleic acids having enhanced cellular uptake | |
CA2291839A1 | Conjugated peptide nucleic acids having enhanced cellular uptake | |
US6300318B1 | Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |